Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance
Open accessThe DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Abstract
The problem of antibiotic resistance is on the rise, with multidrug-resistant strains emerging even to the last resort antibiotics. The drug discovery process is often stalled by stringent cut-offs required for effective drug design. In such a scenario, it is prudent to delve into the varying mechanisms of resistance to existing antibiotics and target them to improve antibiotic efficacy. Nonantibiotic compounds called antibiotic adjuvants which target bacterial resistance can be used in combination with obsolete drugs for an improved therapeutic regime. The field of "antibiotic adjuvants" has gained significant traction in recent years where mechanisms other than β-lactamase inhibition have been explored. This review discusses the multitude of acquired and inherent resistance mechanisms employed by bacteria to resist antibiotic action. The major focus of this review is how to target these resistance mechanisms by the use of antibiotic adjuvants. Different types of direct acting and indirect resistance breakers are discussed including enzyme inhibitors, efflux pump inhibitors, inhibitors of teichoic acid synthesis, and other cellular processes. The multifaceted class of membrane-targeting compounds with poly pharmacological effects and the potential of host immune-modulating compounds have also been reviewed. We conclude with providing insights about the existing challenges preventing clinical translation of different classes of adjuvants, especially membrane-perturbing compounds, and a framework about the possible directions which can be pursued to fill this gap. Antibiotic-adjuvant combinatorial therapy indeed has immense potential to be used as an upcoming orthogonal strategy to conventional antibiotic discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Antibiotics: past, present and future
Hutchings, M. I., Truman, A. W., & Wilkinson, B. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.10.008 · Cited by 2,370
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
The challenge of emerging and re-emerging infectious diseases
Morens, D. M., Folkers, G. K., & Fauci, A. S. (2004) · Nature · doi:10.1038/nature02759 · Cited by 2,103
An overview of the antimicrobial resistance mechanisms of bacteria
C Reygaert, W., & Department of Biomedical Sciences, O. U. W. B. S. O. M. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.3.482 · Cited by 1,893
Agents that increase the permeability of the outer membrane
Vaara, M. (1992) · Microbiological Reviews · doi:10.1128/mr.56.3.395-411.1992 · Cited by 1,879
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Structure of a bacterial multidrug ABC transporter
Dawson, R. J. P., & Locher, K. P. (2006) · Nature · doi:10.1038/nature05155 · Cited by 1,279
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231
Tzouvelekis, L. S., Markogiannakis, A., Psichogiou, M., Tassios, P. T., & Daikos, G. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05035-11 · Cited by 1,191
Multidrug efflux pumps: structure, function and regulation
Du, D., Wang-Kan, X., Neuberger, A., van Veen, H. W., Pos, K. M., Piddock, L. J. V., & Luisi, B. F. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0048-6 · Cited by 1,055
Katayama, Y., Ito, T., & Hiramatsu, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1549-1555.2000 · Cited by 1,038
García-Álvarez, L., Holden, M. T., Lindsay, H., Webb, C. R., Brown, D. F., Curran, M. D., Walpole, E., Brooks, K., Pickard, D. J., Teale, C., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70126-8 · Cited by 939
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Drug combinations: a strategy to extend the life of antibiotics in the 21st century
Tyers, M., & Wright, G. D. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0141-x · Cited by 820
Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., & Lewis, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030540597 · Cited by 761
Kracke, F., Vassilev, I., & Krömer, J. O. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00575 · Cited by 748
The emerging NDM carbapenemases
Nordmann, P., Poirel, L., Walsh, T. R., & Livermore, D. M. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.09.005 · Cited by 663
Mechanisms of Methicillin Resistance in Staphylococcus aureus
Peacock, S. J., & Paterson, G. K. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034516 · Cited by 656
Unemo, M., Golparian, D., Nicholas, R., Ohnishi, M., Gallay, A., & Sednaoui, P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05760-11 · Cited by 653
Diversity, Epidemiology, and Genetics of Class D β-Lactamases
Poirel, L., Naas, T., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01512-08 · Cited by 632
Combination approaches to combat multidrug-resistant bacteria
Worthington, R. J., & Melander, C. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.006 · Cited by 625
Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
Wright, G. D. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.06.009 · Cited by 604
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
King, A. M., Reid-Yu, S. A., Wang, W., King, D. T., De Pascale, G., Strynadka, N. C., Walsh, T. R., Coombes, B. K., & Wright, G. D. (2014) · Nature · doi:10.1038/nature13445 · Cited by 554
Modulating immunity as a therapy for bacterial infections
Hancock, R. E. W., Nijnik, A., & Philpott, D. J. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2745 · Cited by 535
Interplay between β-lactamases and new β-lactamase inhibitors
Bush, K., & Bradford, P. A. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0159-8 · Cited by 531
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Antibiotic Resistance and the MRSA Problem
Vestergaard, M., Frees, D., & Ingmer, H. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0057-2018 · Cited by 490
Pomposiello, P. J., Bennik, M. H. J., & Demple, B. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.13.3890-3902.2001 · Cited by 487
A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens
Song, M., Liu, Y., Huang, X., Ding, S., Wang, Y., Shen, J., & Zhu, K. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0723-z · Cited by 484
TRIMETHOPRIM, A SULPHONAMIDE POTENTIATOR
BUSHBY, S. R. M., & HITCHINGS, G. H. (1968) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1968.tb00475.x · Cited by 466
Aminoglycoside Antibiotics in the 21st Century
Becker, B., & Cooper, M. A. (2013) · ACS Chemical Biology · doi:10.1021/cb3005116 · Cited by 419
Van Bambeke, F., Balzi, E., & Tulkens, P. M. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00291-4 · Cited by 404
Naturally-occurring beta-lactamase inhibitors with antibacterial activity
BROWN, A. G., BUTTERWORTH, D., COLE, M., HANSCOMB, G., HOOD, J. D., READING, C., & ROLINSON, G. N. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.668 · Cited by 399
Shore, A. C., Deasy, E. C., Slickers, P., Brennan, G., O'Connell, B., Monecke, S., Ehricht, R., & Coleman, D. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00187-11 · Cited by 383
Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter
Neyfakh, A. A., Borsch, C. M., & Kaatz, G. W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.1.128 · Cited by 361
Stokes, J. M., MacNair, C. R., Ilyas, B., French, S., Côté, J.-P., Bouwman, C., Farha, M. A., Sieron, A. O., Whitfield, C., Coombes, B. K., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.28 · Cited by 340
Current status and prospects of HIV treatment
Cihlar, T., & Fordyce, M. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.03.004 · Cited by 337
Proliferation and significance of clinically relevant β‐lactamases
Bush, K. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12023 · Cited by 337
Antibiotic Adjuvants: Diverse Strategies for Controlling Drug‐Resistant Pathogens
Gill, E. E., Franco, O. L., & Hancock, R. E. W. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12478 · Cited by 319
Liu, B., Trout, R. E. L., Chu, G.-H., McGarry, D., Jackson, R. W., Hamrick, J. C., Daigle, D. M., Cusick, S. M., Pozzi, C., De Luca, F., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01518 · Cited by 312
THE PROTON MOTIVE FORCE IN BACTERIA: A CRITICAL ASSESSMENT OF METHODS
Kashket, E. R. (1985) · Annual Review of Microbiology · doi:10.1146/annurev.mi.39.100185.001251 · Cited by 309
Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria
Zhao, W.-H., & Hu, Z.-Q. (2013) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2012.691460 · Cited by 302
Small multidrug resistance proteins: A multidrug transporter family that continues to grow
Bay, D. C., Rommens, K. L., & Turner, R. J. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.015 · Cited by 299
New Delhi Metallo-β-Lactamase: Structural Insights into β-Lactam Recognition and Inhibition
King, D. T., Worrall, L. J., Gruninger, R., & Strynadka, N. C. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303579d · Cited by 297
Roell, K. R., Reif, D. M., & Motsinger-Reif, A. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00158 · Cited by 295
Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids
Brown, S., Xia, G., Luhachack, L. G., Campbell, J., Meredith, T. C., Chen, C., Winstel, V., Gekeler, C., Irazoqui, J. E., Peschel, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209126109 · Cited by 290
Campbell, J., Singh, A. K., Santa Maria, J. P., Kim, Y., Brown, S., Swoboda, J. G., Mylonakis, E., Wilkinson, B. J., & Walker, S. (2011) · ACS Chemical Biology · doi:10.1021/cb100269f · Cited by 289
Durand-Réville, T. F., Guler, S., Comita-Prevoir, J., Chen, B., Bifulco, N., Huynh, H., Lahiri, S., Shapiro, A. B., McLeod, S. M., Carter, N. M., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.104 · Cited by 285
Antibiotic Adjuvants: Make Antibiotics Great Again!
Douafer, H., Andrieu, V., Phanstiel, O., & Brunel, J. M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01781 · Cited by 272
Yang, J. H., Bhargava, P., McCloskey, D., Mao, N., Palsson, B. O., & Collins, J. J. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.10.020 · Cited by 267
Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update
Blair, J. M., & Piddock, L. J. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.07.003 · Cited by 266
Improved antimicrobial peptides based on acyl-lysine oligomers
Radzishevsky, I. S., Rotem, S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., & Mor, A. (2007) · Nature Biotechnology · doi:10.1038/nbt1309 · Cited by 256
Brem, J., Cain, R., Cahill, S., McDonough, M. A., Clifton, I. J., Jiménez-Castellanos, J.-C., Avison, M. B., Spencer, J., Fishwick, C. W. G., & Schofield, C. J. (2016) · Nature Communications · doi:10.1038/ncomms12406 · Cited by 255
Metformin Restores Tetracyclines Susceptibility against Multidrug Resistant Bacteria
Liu, Y., Jia, Y., Yang, K., Li, R., Xiao, X., Zhu, K., & Wang, Z. (2020) · Advanced Science · doi:10.1002/advs.201902227 · Cited by 245
Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations
Vargiu, A. V., & Nikaido, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218348109 · Cited by 231
Unemo, M., & Shafer, W. M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06215.x · Cited by 230
Smet, A., Martel, A., Persoons, D., Dewulf, J., Heyndrickx, M., Catry, B., Herman, L., Haesebrouck, F., & Butaye, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01285-07 · Cited by 219
Gao, W., Chua, K., Davies, J. K., Newton, H. J., Seemann, T., Harrison, P. F., Holmes, N. E., Rhee, H.-W., Hong, J.-I., Hartland, E. L., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000944 · Cited by 218
Inhibition of WTA Synthesis Blocks the Cooperative Action of PBPs and Sensitizes MRSA to β-Lactams
Farha, M. A., Leung, A., Sewell, E. W., D’Elia, M. A., Allison, S. E., Ejim, L., Pereira, P. M., Pinho, M. G., Wright, G. D., & Brown, E. D. (2013) · ACS Chemical Biology · doi:10.1021/cb300413m · Cited by 216
Isobologram Analysis: A Comprehensive Review of Methodology and Current Research
Huang, R.-Y., Pei, L., Liu, Q., Chen, S., Dou, H., Shu, G., Yuan, Z.-X., Lin, J., Peng, G., Zhang, W., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01222 · Cited by 216
Sjuts, H., Vargiu, A. V., Kwasny, S. M., Nguyen, S. T., Kim, H.-S., Ding, X., Ornik, A. R., Ruggerone, P., Bowlin, T. L., Nikaido, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602472113 · Cited by 207
Kerantzas, C. A., & Jacobs, W. R. (2017) · mBio · doi:10.1128/mbio.01586-16 · Cited by 202
Characterization of a Novel Pyranopyridine Inhibitor of the AcrAB Efflux Pump of Escherichia coli
Opperman, T. J., Kwasny, S. M., Kim, H.-S., Nguyen, S. T., Houseweart, C., D'Souza, S., Walker, G. C., Peet, N. P., Nikaido, H., & Bowlin, T. L. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01866-13 · Cited by 202
Distinct and essential morphogenic functions for wall‐ and lipo‐teichoic acids in Bacillus subtilis
Schirner, K., Marles‐Wright, J., Lewis, R. J., & Errington, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.25 · Cited by 189
Morinaka, A., Tsutsumi, Y., Yamada, M., Suzuki, K., Watanabe, T., Abe, T., Furuuchi, T., Inamura, S., Sakamaki, Y., Mitsuhashi, N., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv166 · Cited by 183
A structural view of the antibiotic degradation enzyme NDM-1 from a superbug
Guo, Y., Wang, J., Niu, G., Shui, W., Sun, Y., Zhou, H., Zhang, Y., Yang, C., Lou, Z., & Rao, Z. (2011) · Protein & Cell · doi:10.1007/s13238-011-1055-9 · Cited by 177
Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design
Linciano, P., Cendron, L., Gianquinto, E., Spyrakis, F., & Tondi, D. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00247 · Cited by 173
Inhibitors of Multidrug Resistant Efflux Systems in Bacteria
Zechini, B., & Versace, I. (2009) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489109787236256 · Cited by 172
Kern, W. V., Steinke, P., Schumacher, A., Schuster, S., Baum, H. V., & Bohnert, J. A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki445 · Cited by 172
Microbial Efflux Pump Inhibition: Tactics and Strategies
Tegos, G. P., Haynes, M. K., Strouse, J. J., Khan, M. M. T., Bologa, C., Oprea, T. I., & Sklar, L. A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795703726 · Cited by 171
A Common Platform for Antibiotic Dereplication and Adjuvant Discovery
Cox, G., Sieron, A. O., King, A. M., Pascale, G. D., Pawlowski, A. C., Koteva, K. K., & Wright, G. D. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.11.011 · Cited by 168
Papp‐Wallace, K. M., Nguyen, N. Q., Jacobs, M. R., Bethel, C. R., Barnes, M. D., Kumar, V., Bajaksouzian, S., Rudin, S. D., Rather, P. N., Bhavsar, S., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00091 · Cited by 168
Membrane‐Active Small Molecules: Designs Inspired by Antimicrobial Peptides
Ghosh, C., & Haldar, J. (2015) · ChemMedChem · doi:10.1002/cmdc.201500299 · Cited by 167
Self-citationEmerging infectious diseases and pandemic potential: status quo and reducing risk of global spread
McCloskey, B., Dar, O., Zumla, A., & Heymann, D. L. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70846-1 · Cited by 165
Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide
Danner, R. L., Joiner, K. A., Rubin, M., Patterson, W. H., Johnson, N., Ayers, K. M., & Parrillo, J. E. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1428 · Cited by 161
Klingler, F.-M., Wichelhaus, T. A., Frank, D., Cuesta-Bernal, J., El-Delik, J., Müller, H. F., Sjuts, H., Göttig, S., Koenigs, A., Pos, K. M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501844d · Cited by 161
Kaye, K. S., Belley, A. C., Barth, P., Lahlou, O., Knechtle, P., Motta, P., & Vélicitat, P. (2022) · JAMA · doi:10.1001/jama.2022.17034 · Cited by 158
Papp‐Wallace, K. M. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1660772 · Cited by 156
Kojima, S., & Nikaido, H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310333110 · Cited by 154
Discovery of a Small Molecule that Blocks Wall Teichoic Acid Biosynthesis in Staphylococcus aureus
Swoboda, J. G., Meredith, T. C., Campbell, J., Brown, S., Suzuki, T., Bollenbach, T., Malhowski, A. J., Kishony, R., Gilmore, M. S., & Walker, S. (2009) · ACS Chemical Biology · doi:10.1021/cb900151k · Cited by 151
Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes
Hinchliffe, P., González, M. M., Mojica, M. F., González, J. M., Castillo, V., Saiz, C., Kosmopoulou, M. N., Tooke, C. L., Llarrull, L. I., Mahler, G., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601368113 · Cited by 151
O’Daniel, P. I., Peng, Z., Pi, H., Testero, S. A., Ding, D., Spink, E., Leemans, E., Boudreau, M. A., Yamaguchi, T., Schroeder, V. A., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja500053x · Cited by 150
Ebselen as a potent covalent inhibitor of New Delhi metallo-β-lactamase (NDM-1)
Chiou, J. A., Wan, S., Chan, K., So, P., He, D., Chan, E. W., Chan, T. H., Wong, K., Jiang, T., & Chen, S. (2015) · Chemical Communications · doi:10.1039/c5cc02594j · Cited by 150
Corbett, D. F., Wise, A., Langley, T., Skinner, K., Trimby, E., Birchall, S., Dorali, A., Sandiford, S. K., Williams, J., Warn, P. A., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00200-17 · Cited by 148
Moyá, B., Barceló, I. M., Bhagwat, S., Patel, M. V., Bou, G., Papp‐Wallace, K. M., Bonomo, R. A., & Oliver, A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02529-16 · Cited by 145
Dolejska, M., Villa, L., Poirel, L., Nordmann, P., & Carattoli, A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks357 · Cited by 144
Taking aim at wall teichoic acid synthesis: new biology and new leads for antibiotics
Sewell, E. W., & Brown, E. D. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.100 · Cited by 143
Structure, mechanism and cooperation of bacterial multidrug transporters.
Du, D., van Veen, H., Murakami, S., Pos, K., & Luisi, B. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.07.015 · Cited by 139
Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections
Heo, Y. (2021) · Drugs · doi:10.1007/s40265-021-01471-8 · Cited by 139
Discovery of Wall Teichoic Acid Inhibitors as Potential Anti-MRSA β-Lactam Combination Agents
Wang, H., Gill, C. J., Lee, S. H., Mann, P., Zuck, P., Meredith, T. C., Murgolo, N., She, X., Kales, S., Liang, L., et al. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.11.013 · Cited by 136
Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics
Vaara, M. (2019) · Molecules · doi:10.3390/molecules24020249 · Cited by 136
Brogden, R. N., Carmine, A., Heel, R. C., Morley, P. A., Speight, T. M., & Avery, G. S. (1981) · Drugs · doi:10.2165/00003495-198122050-00001 · Cited by 131
Huber, J. L., Donald, R. G. K., Lee, S. H., Jarantow, L. W., Salvatore, M. J., Meng, X., Painter, R. E., Onishi, R., Occi, J., Dorso, K., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.05.012 · Cited by 130
Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical Use
Carcione, D., Siracusa, C., Sulejmani, A., Leoni, V., & Intra, J. (2021) · Antibiotics · doi:10.3390/antibiotics10080995 · Cited by 128
Abdali, N., Parks, J. M., Haynes, K. M., Chaney, J. L., Green, A. T., Wolloscheck, D., Walker, J. K., Rybenkov, V. V., Baudry, J. Y., Smith, J. C., et al. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00167 · Cited by 127
Wesseling, C. M. J., & Martin, N. I. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00193 · Cited by 124
Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies
Dhanda, G., Sarkar, P., Samaddar, S., & Haldar, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01093 · Cited by 121
Self-citationLee, S. H., Wang, H., Labroli, M. A., Koseoglu, S., Zuck, P. D., Mayhood, T., Gill, C., Mann, P. A., Sher, X., Ha, S., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7364 · Cited by 120
Novel Inhibitors of Erm Methyltransferases from NMR and Parallel Synthesis
Hajduk, P. J., Dinges, J., Schkeryantz, J. M., Janowick, D. A., Kaminski, M., Tufano, M. D., Augeri, D. J., Petros, A. M., Nienaber, V. L., Zhong, P., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990293a · Cited by 119
Can β-Lactam Antibiotics Be Resurrected to Combat MRSA?
Foster, T. J. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.06.005 · Cited by 117
Malléa, M., Mahamoud, A., Chevalier, J., Alibert, S., Brouant, P., Barbe, J., & Pagès, J. (2003) · Biochemical Journal · doi:10.1042/bj20030963 · Cited by 117
Inhibition of Aminoglycoside Antibiotic Resistance Enzymes by Protein Kinase Inhibitors
Daigle, D. M., McKay, G. A., & Wright, G. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24755 · Cited by 114
Bhavsar, A. P., Erdman, L. K., Schertzer, J. W., & Brown, E. D. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.23.7865-7873.2004 · Cited by 112
Farha, M. A., Czarny, T. L., Myers, C. L., Worrall, L. J., French, S., Conrady, D. G., Wang, Y., Oldfield, E., Strynadka, N. C. J., & Brown, E. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511751112 · Cited by 111
Treatment of Gram-negative bacterial infections by potentiation of antibiotics
Zabawa, T. P., Pucci, M. J., Parr, T. R., & Lister, T. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.05.005 · Cited by 109
French, S., Farha, M. A., Ellis, M. J., Sameer, Z., Côté, J., Cotroneo, N. S., Lister, T., Rubio, A., & Brown, E. D. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00159 · Cited by 108
Lavigne, J., Sotto, A., Nicolas-Chanoine, M.-H., Bouziges, N., Pagès, J., & Davin‐Regli, A. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.10.010 · Cited by 106
Uses of polypills for cardiovascular disease and evidence to date
Huffman, M. D., Xavier, D., & Perel, P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30553-6 · Cited by 103
Sabatini, S., Gosetto, F., Serritella, S., Manfroni, G., Tabarrini, O., Iraci, N., Brincat, J. P., Carosati, E., Villarini, M., Kaatz, G. W., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201446h · Cited by 99
Structure–Activity Relationship for the Oxadiazole Class of Antibiotics
Spink, E., Ding, D., Peng, Z., Boudreau, M. A., Leemans, E., Lastochkin, E., Song, W., Lichtenwalter, K., O’Daniel, P. I., Testero, S. A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501661f · Cited by 99
Poulou, A., Voulgari, E., Vrioni, G., Koumaki, V., Xidopoulos, G., Chatzipantazi, V., Markou, F., & Tsakris, A. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01244-13 · Cited by 92
Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria
Yarlagadda, V., Manjunath, G. B., Sarkar, P., Akkapeddi, P., Krishnamoorthy, P., Shome, B. R., Ravikumar, R., & Haldar, J. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00114 · Cited by 91
Self-citationBroad-Spectrum Peptide Inhibitors of Aminoglycoside Antibiotic Resistance Enzymes
Boehr, D. D., Draker, K.-A., Koteva, K. K., Bains, M., Hancock, R. E. W., & Wright, G. D. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00026-7 · Cited by 90
Jawetz, E., Gunnison, J. B., Bruff, J. B., & Coleman, V. R. (1952) · Journal of Bacteriology · doi:10.1128/jb.64.1.29-39.1952 · Cited by 88
A Small Molecule Discrimination Map of the Antibiotic Resistance Kinome
Shakya, T., Stogios, P. J., Waglechner, N., Evdokimova, E., Ejim, L. J., Blanchard, J., McArthur, A. G., Savchenko, A. V., & Wright, G. D. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.10.018 · Cited by 85
Inhibition of Bacterial Multidrug Resistance by Celecoxib, a Cyclooxygenase-2 Inhibitor
Kalle, A. M., & Rizvi, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00735-10 · Cited by 83
A Forward Chemical Screen Identifies Antibiotic Adjuvants in Escherichia coli
Taylor, P. L., Rossi, L., Pascale, G. D., & Wright, G. D. (2012) · ACS Chemical Biology · doi:10.1021/cb300269g · Cited by 81
NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors
Li, G., Abboud, M. I., Brem, J., Someya, H., Lohans, C. T., Yang, S., SPENCER, J. M., Wareham, D. W., McDonough, M. A., & Schofield, C. J. (2017) · Chemical Science · doi:10.1039/c6sc04524c · Cited by 80
Uppu, D. S. S. M., Konai, M. M., Baul, U., Singh, P., Siersma, T. K., Samaddar, S., Vemparala, S., Hamoen, L. W., Narayana, C., & Haldar, J. (2016) · Chemical Science · doi:10.1039/c6sc00615a · Cited by 79
Self-citationJanardhanan, J., Bouley, R. A., Martínez‐Caballero, S., Peng, Z., Batuecas-Mordillo, M., Meisel, J. E., Ding, D., Schroeder, V. A., Wolter, W. R., Mahasenan, K. V., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02637-18 · Cited by 78
Yarlagadda, V., Samaddar, S., Krishnamoorthy, P., Shome, B. R., & Haldar, J. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201507567 · Cited by 77
Self-citation7-Hydroxytropolone: an inhibitor of aminoglycoside-2"-O-adenylyltransferase
Allen, N. E., Alborn, W. E., Hobbs, J. N., & Kirst, H. A. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.5.824 · Cited by 70
Mann, P. A., Müller, A., Xiao, L., Pereira, P. M., Yang, C., Lee, S. H., Wang, H., Trzeciak, J., Schneeweis, J. E., dos Santos, M. M., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400487f · Cited by 69
Bush, K. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00243 · Cited by 69
Emerging Roles of Glycopeptide Antibiotics: Moving beyond Gram-Positive Bacteria
Acharya, Y., Bhattacharyya, S., Dhanda, G., & Haldar, J. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00367 · Cited by 66
Self-citationChallenges in the Development of a Thiol-Based Broad-Spectrum Inhibitor for Metallo-β-Lactamases
Büttner, D., Kramer, J. S., Klingler, F., Wittmann, S. K., Hartmann, M., Kurz, C. G., Kohnhäuser, D., Weizel, L., Brüggerhoff, A., Frank, D., et al. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00129 · Cited by 66
Stogios, P. J., Spanogiannopoulos, P., Evdokimova, E., Egorova, O., Shakya, T., Todorovic, N., Capretta, A. A., Wright, G. D., & Savchenko, A. V. (2013) · Biochemical Journal · doi:10.1042/bj20130317 · Cited by 65
Yarlagadda, V., Medina, R., & Wright, G. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-64756-0 · Cited by 65
Rationale for use of antimicrobial combinations
Moellering, R. C. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90088-8 · Cited by 62
Jin, W., Xu, C., Cheng, Q., Qi, X. L., Gao, W., Zheng, Z., Chan, E. W., Leung, Y., Chan, T. H., Wong, K., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.06.007 · Cited by 57
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2
Drusano, G. L., Hope, W. W., MacGowan, A. P., & Louie, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02231-15 · Cited by 55
On the mechanism of solute uptake in Pseudomonas
Hancock, R. E. W. (2003) · Frontiers in bioscience · doi:10.2741/1075 · Cited by 54
Structure-based classification of class A beta-lactamases, an update
Philippon, A., Jacquier, H., Ruppé, É., & Labia, R. (2019) · Current Research in Translational Medicine · doi:10.1016/j.retram.2019.05.003 · Cited by 54
Trout, R. E. L., Zulli, A. L., Mesaros, E. F., Jackson, R. W., Boyd, S. A., Liu, B., Hamrick, J. C., Daigle, D. M., Chatwin, C. L., John, K., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00437 · Cited by 52
Lomovskaya, O., Tsivkovski, R., Sun, D., Reddy, R., Totrov, M. M., Hecker, S. J., Griffith, D. C., Loutit, J., & Dudley, M. N. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.697180 · Cited by 52
Katsu, T., Nakagawa, H., & Yasuda, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1073-1079.2002 · Cited by 52
Chu, J., Vila‐Farrés, X., Inoyama, D., Gallardo‐Macias, R., Jaskowski, M., Satish, S., Freundlich, J. S., & Brady, S. F. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00056 · Cited by 51
Petropoulou, D., Siopi, M., Vourli, S., & Pournaras, S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.814530 · Cited by 50
Hirsch, D. R., Cox, G., D’Erasmo, M. P., Shakya, T., Meck, C., Mohd, N., Wright, G. D., & Murelli, R. P. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.09.037 · Cited by 50
The TFPI-2 Derived Peptide EDC34 Improves Outcome of Gram-Negative Sepsis
Papareddy, P., Kalle, M., Sørensen, O. E., Malmsten, M., Mörgelin, M., & Schmidtchen, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003803 · Cited by 49
A macrophage-stimulating compound from a screen of microbial natural products
Perry, J. A., Koteva, K. K., Verschoor, C. P., Wang, W., Bowdish, D. M. E., & Wright, G. D. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.83 · Cited by 47
Approaches for the discovery of metallo‐β‐lactamase inhibitors: A review
Shi, C., Chen, J., Kang, X., Shen, X., Lao, X., & Zheng, H. (2019) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13526 · Cited by 47
Uppu, D. S. S. M., Konai, M. M., Sarkar, P., Samaddar, S., Fensterseifer, I. C. M., Faria-Junior, C., Krishnamoorthy, P., Shome, B. R., Franco, O. L., & Haldar, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183263 · Cited by 46
Self-citationIn Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors
Cain, R. M., Brem, J., Zollman, D., McDonough, M. A., Johnson, R. M., SPENCER, J. M., Makena, A., Abboud, M. I., Cahill, S. T., Lee, S. Y., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01728 · Cited by 46
Vancomycin Analogue Restores Meropenem Activity against NDM-1 Gram-Negative Pathogens
Yarlagadda, V., Sarkar, P., Samaddar, S., Manjunath, G. B., Mitra, S. D., Krishnamoorthy, P., Shome, B. R., & Haldar, J. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00011 · Cited by 46
Self-citationChemical Screen for Vancomycin Antagonism Uncovers Probes of the Gram-Negative Outer Membrane
Klobucar, K., Côté, J., French, S., Borrillo, L., Guo, A. B. Y., Serrano‐Wu, M. H., Lee, K. K., Hubbard, B. K., Johnson, J. W., Gaulin, J. L., et al. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00179 · Cited by 45
Konai, M. M., & Haldar, J. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00221 · Cited by 45
Self-citationMyers, C. L., Li, F. K. K., Koo, B., El-Halfawy, O. M., French, S., Gross, C. A., Strynadka, N. C. J., & Brown, E. D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.760447 · Cited by 45
Foxley, M. A., Wright, S. N., Lam, A. K., Friedline, A. W., Strange, S., Xiao, M. T., Moen, E. L., & Rice, C. V. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00285 · Cited by 42
Mode of action of novel polyamines increasing the permeability of bacterial outer membrane
Yasuda, K., Ohmizo, C., & Katsu, T. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.01.006 · Cited by 42
Kehoe, L. E., Snidwongse, J., Courvalin, P., Rafferty, J. B., & Murray, I. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303766200 · Cited by 40
Uppu, D. S. S. M., Manjunath, G. B., Yarlagadda, V., Kaviyil, J. E., Ravikumar, R., Krishnamoorthy, P., Shome, B. R., & Haldar, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119422 · Cited by 40
Self-citationAntiplasmodial Activity of Lauryl-Lysine Oligomers
Radzishevsky, I. S., Krugliak, M., Ginsburg, H., & Mor, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-06 · Cited by 37
Dik, D. A., Madukoma, C. S., Tomoshige, S., Kim, C. K., Lastochkin, E., Boggess, B., Fisher, J. F., Shrout, J. D., & Mobashery, S. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.8b01025 · Cited by 37
Feder, M., Purta, E., Kościński, Ł., Čubrilo, S., Vlahoviček, G. M., & Bujnicki, J. M. (2007) · ChemMedChem · doi:10.1002/cmdc.200700201 · Cited by 37
Tomoshige, S., Dik, D. A., Akabane‐Nakata, M., Madukoma, C. S., Fisher, J. F., Shrout, J. D., & Mobashery, S. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00105 · Cited by 36
Ramirez, D., Berry, L., Domalaon, R., Brizuela, M., & Schweizer, F. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00017 · Cited by 36
Vancomycin Derivative Inactivates Carbapenem-Resistant Acinetobacter baumannii and Induces Autophagy
Sarkar, P., Samaddar, S., Ammanathan, V., Yarlagadda, V., Ghosh, C., Shukla, M., Kaul, G., Manjithaya, R. R., Chopra, S., & Haldar, J. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00091 · Cited by 36
Self-citationAssays to Detect and Characterize Synthetic Agents that Inhibit the ErmC Methyltransferase.
Clancy, J., Schmieder, B. J., Petitpas, J. W., MANOUSOS, M., WILLIAMS, J. A., FAIELLA, J. A., Girard, A. E., & McGuirk, P. R. (1995) · The Journal of Antibiotics · doi:10.7164/antibiotics.48.1273 · Cited by 36
In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams
Janardhanan, J., Meisel, J. E., Ding, D., Schroeder, V. A., Wolter, W. R., Mobashery, S., & Chang, M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00787-16 · Cited by 35
Pursuit of next-generation glycopeptides: a journey with vancomycin
Acharya, Y., Dhanda, G., Sarkar, P., & Haldar, J. (2022) · Chemical Communications · doi:10.1039/d1cc06635h · Cited by 35
Self-citationStructure-Based Discovery of Lipoteichoic Acid Synthase Inhibitors
Wezen, X. C., Chandran, A., Eapen, R., Waters, E. M., Bricio-Moreno, L., Tosi, T., Dolan, S. K., Millership, C., Kadioglu, A., Gründling, A., et al. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00300 · Cited by 35
Aryl-alkyl-lysines: Membrane-Active Fungicides That Act against Biofilms of Candida albicans
Ghosh, C., Yadav, V., Younis, W., Mohammad, H. T., Hegazy, Y. A., Seleem, M. N., Sanyal, K., & Haldar, J. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00192 · Cited by 35
Self-citationThe outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide.
Vaara, M. (1991) · PubMed · Cited by 34
Moon, S. H., Zhang, X., Zheng, G., Meeker, D. G., Smeltzer, M. S., & Huang, E. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01064 · Cited by 34
Konai, M. M., Samaddar, S., Bocchinfuso, G., Santucci, V., Stella, L., & Haldar, J. (2018) · Chemical Communications · doi:10.1039/c8cc01926f · Cited by 31
Self-citationMacromolecular Nanotherapeutics and Antibiotic Adjuvants to Tackle Bacterial and Fungal Infections
Dey, R. K., Mukherjee, S., Barman, S., & Haldar, J. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202100182 · Cited by 30
Self-citationPreclinical Development of Pentamidine Analogs Identifies a Potent and Nontoxic Antibiotic Adjuvant
MacNair, C. R., Farha, M. A., Serrano‐Wu, M. H., Lee, K. K., Hubbard, B. K., Côté, J., Carfrae, L. A., Tu, M. M., Gaulin, J. L., Hunt, D. K., et al. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00482 · Cited by 29
Alfei, S., & Zuccari, G. (2022) · Pharmaceuticals · doi:10.3390/ph15030384 · Cited by 27
Barman, S., Mukherjee, S., Ghosh, S., & Haldar, J. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00732 · Cited by 27
Self-citationNguyen, L. P., Pinto, N. A., Vu, T. N., Lee, H.-S., Cho, Y. L., Byun, J., D’Souza, R., & Yong, D. (2020) · Antibiotics · doi:10.3390/antibiotics9050267 · Cited by 25
Wesseling, C. M. J., Slingerland, C. J., Veraar, S., Lok, S., & Martin, N. I. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00466 · Cited by 25
Rapid Inhibitor Discovery by Exploiting Synthetic Lethality
Muscato, J. D., Morris, H. G., Mychack, A., Rajagopal, M., Baidin, V., Hesser, A. R., Lee, W., İnecik, K., Wilson, L. J., Kraml, C. M., et al. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c12697 · Cited by 24
Target‐Based Whole‐Cell Screening by 1H NMR Spectroscopy
Ma, J., Cao, Q., McLeod, S. M., Ferguson, K., Gao, N., Breeze, A. L., & Hu, J. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201410701 · Cited by 24
Domalaon, R., Brizuela, M., Eisner, B., Findlay, B., Zhanel, G. G., & Schweizer, F. (2018) · Amino Acids · doi:10.1007/s00726-018-2673-9 · Cited by 24
Sabet, M., Tarazi, Z., & Griffith, D. C. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01267-20 · Cited by 22
Cooperative Membrane Damage as a Mechanism for Pentamidine–Antibiotic Mutual Sensitization
Zhou, Y., Huang, W., Lei, E. F.-C., Yang, A., Li, Y., Wen, K., Wang, M., Li, L., Chen, Z., Zhou, C., et al. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00613 · Cited by 17
Azaindole Based Potentiator of Antibiotics against Gram-Negative Bacteria
Sharma, S., Rao, R., Reeve, S. M., Phelps, G. A., Bharatham, N., Katagihallimath, N., Ramachandran, V., Raveendran, S., Sarma, M., Nath, A., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00171 · Cited by 17
Dhanda, G., Mukherjee, R., Basak, D., & Haldar, J. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00092 · Cited by 17
Self-citationBarman, S., Dhanda, G., Naik, P., Mukherjee, R., Jolly, L., Joseph, J., & Haldar, J. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202100234 · Cited by 12
Self-citationMUKHERJEE, S., Ghosh, S., & Haldar, J. (2020) · Bulletin of Materials Science · doi:10.1007/s12034-020-02284-3 · Cited by 10
Self-citationSchweizer, L., Ramirez, D., & Schweizer, F. (2022) · Antibiotics · doi:10.3390/antibiotics11030335 · Cited by 10
Zaknoon, F., Meir, O., & Mor, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111947 · Cited by 7
Speri, E., Fishovitz, J., & Mobashery, S. (2018) · MedChemComm · doi:10.1039/c8md00479j · Cited by 5
Cited by
Ghosh, S., Basu, S., Anbarasu, A., & Ramaiah, S. (2025) · Phytotherapy Research · doi:10.1002/ptr.8365 · Cited by 33
Metadata
- Authors
- Dhanda, G., Acharya, Y., & Haldar, J.
- Venue
- ACS Omega
- Publisher
- American Chemical Society (ACS)
- Published
- 2023-03-14
- Volume
- 8
- Issue
- 12
- Pages
- 10757-10783
- ISSN
- 2470-1343 (ISSN-L)
- OpenAlex
- W4324140019
- Cited by
- 162
- References
- 190
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.